On September 21, 2020, Aurisco Pharmaceutical Co., Ltd. (Stock code: 605116) was officially listed on the Shanghai Stock Exchange. The per share issuing price is RMB8.37, number of shares issued is 41 million shares, raising a capital of RMB 343 millions.

This listing is an important leap forward in the milestone of Aurisco’s growth. Taking this opportunity, the company is committed develop value-added APIs with high technical threshold and starts to carry out development and registration of finished dosages. The company will further explore domestic market and penetrate international market, actively participate in the global competition and increase the market share of the company's products, to become a first-class pharmaceutical enterprise at home and abroad.